Oramed Pharmaceuticals (ORMP) Capital Expenditures (2009 - 2026)
Oramed Pharmaceuticals (ORMP) reported Capital Expenditures of $2,000 for Q2 2026, down 50.0% from $4,000 a year earlier and down 60.0% from the prior quarter.
Powered by 
Analysis
Oramed Pharmaceuticals (ORMP) Capital Expenditures (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Oramed Pharmaceuticals' Capital Expenditures came in at $9,000, down 60.9% year-over-year; for FY2025, it came in at $9,000, down 50.0% from FY2024.
- Capital Expenditures has declined for three consecutive years, with a five-year compound annual growth rate of -35.7% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $18,000 in FY2024 (-92.9%), $254,000 in FY2023 (-48.8%), $496,000 in FY2022 and $9,000 in FY2021.
- Five-year quarterly Capital Expenditures spans a low of $2,000 in Q3 2021 and a high of $308,000 in Q4 2022.
- Year over year, Capital Expenditures gained in three of the last six quarters, with growth averaging 27.9%.
- The high point for year-over-year Capital Expenditures in five years was Q1 2023 (growth of 323.4%); the low point was Q4 2023 (a decline of 99.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Oramed Pharmaceuticals | 164.02 Mn | -170.72 Mn | - | 2,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 32,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 199,000.00 |
| Dec 31, 2022 | 308,000.00 |
| Sep 30, 2022 | 121,000.00 |
| Jun 30, 2022 | 20,000.00 |
| Mar 31, 2022 | 47,000.00 |
| Feb 28, 2021 | 33,000.00 |
| Nov 30, 2020 | 313,000.00 |
| Aug 31, 2020 | 79,000.00 |
| Nov 30, 2019 | 3,000.00 |
API Access
Oramed Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ORMP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ORMP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ORMP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();